Urinary albumin levels in the normal range determine arterial wall thickness in adults with Type 2 diabetes: A FIELD substudy

Diabetic Medicine

Volumn 22, Issue 11, 2005, Pages 1558-1565

  Keech, Anthony C ^a,b   Grieve, S M ^a   Patel, A ^a   Griffiths, K ^b   Skiltont, M ^b   Watts, G F ^c   Marwick, T H ^d   Groshens, M ^a   Celermajer, D S ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cardiovascular disease; Intima media thickness; Type 2 diabetes; Urine albumin

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CHRONIC DISEASE; DISEASE DURATION; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; MICROALBUMINURIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; URINE LEVEL;

AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CAROTID ARTERIES; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS;

EID: 27844536847     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01688.x     Document Type: Article

References (39)

1. Stamler J, Vaccaro O, Neaton JD, Westworth D. Diabetes and other risk factors and the 12 year cardiovascular mortality for men screened for the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
2. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol 1993; 22: 1788-1794.
3. Chambless LE, Folsom AR, Davis V, Sharrett R, Heiss G, Sorlie P et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998. Am J Epidemiol 2002; 155: 38-47.
4. Ebrahim S, Papacosta O, Whincup P, Wannamathee G, Walker M, Nicolaides AN et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women. The British Regional Heart Study. Stroke 1999; 30: 814-850.
5. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary disease. Arteriorioscler Thromb 1991; 11: 1245-1249.
6. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction. The Rotterdam study. Circulation 1996; 97: 1432-1437.
7. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997; 146: 483-494.
8. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340: 14-22.
9. Iglesias del Sol A, Bots ML, Grobbee DE, Hofman A, Witteman JC. Carotid intima-media thickness at different sites: relation to incident myocardial infarction; the Rotterdam study. Eur Heart J 2002; 23: 934-940.
10. FIELD Study Investigators. The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. ISRCTN 64783481. Cardiovasc Diabetol 2004; 3: 9.
11. Mohan V, Ravikumar R, Rani S, Deepa R. Intimal medial thickness of the carotid artery in South Indian diabetic and non-diabetic subjects: the Chennai Urban Population Study (CUPS). Diabetologia 2000; 43: 494-499.
12. Yamasaki Y, Kodama M, Nishizawa H, Sakamoto K, Matsuhisa M, Kajimoto Y et al. Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care 2000; 23: 1310-1315.
13. Temelkova-Kurktschiev T, Koehler C, Schaper F, Henkel E, Hahnefeld A, Fuecker K et al. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals. Diabetologia 1998; 41: 706-712.
14. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19: 1992-1997.
15. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 617-624.
16. Wachtell K, Olsen MH, Dahlof B, Devereux RB, Kjeldsen SE, Nieminen MS et al. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens 2002; 20: 405-412.
17. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426.
18. Morgensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetics. N Engl J Med 1984; 9: 356-360.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. Gatling W, Knight C, Mullee MA, Hill RD. Microalbuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests. Diabet Med 1988; 5: 343-347.
21. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993; 87: S56-S65.
22. Adams MR, Nakagomi A, Keech A, Robinson J, McCredie R, Bailey BP et al. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation 1995; 92: 2127-2134.
23. Furberg CD, Pitt B, Byington RP, Park JS, McGovern ME. Reduction in coronary events during treatment with pravastatin. PLAC I and PLAC II Investigators. Pravastatin Limitation of Atherosclerosis in the Coronary Arteries. Am J Cardiol 1995; 76: 60C-63C.
24. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu C, Liu C et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized, controlled clinical trial. Ann Intern Med 1996; 124: 548-556.
25. Lange LA, Bowden DW, Langefeld CD, Wagenknecht LE, Carr JJ, Rich SS et al. Heritability of carotid artery intima-medial thickness in type 2 diabetes. Stroke 2002; 33: 1876-1881.
26. Niskanen L, Rauramaa R, Miettinen H, Haffner SM, Mercuri M, Uusitupa M. Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects. Stroke 1996; 27: 1986-1992.
27. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 2002; 51: 1157-1165.
28. Willey KA, Kidd JF, Harris JP, Xu ZR, Yue DK. Albuminuria is an independent predictor of carotid intima-media thickness and atherosclerosis in NIDDM patients. Diabetes Care 1995; 18: 1502-1503.
29. Agewall S, Wikstrand J, Ljungman S, Fagerberg B. Urinary albumin excretion is associated with the intima-media thickness of the carotid artery in hypertensive men with non-insulin-dependent diabetes mellitus. J Hypertens 1995; 13: 463-469.
30. Mykkanen L, Zaccaro DJ, O'Leary DH, Howard G, Robbins DC, Haffner SM. Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1997; 28: 1710-1716.
31. Diercks GF, Stroes ES, Van Boven AJ, Van Roon AM, Hillege HL, De Jong PE et al. Difference in the relation between urinary albumin excretion and carotid intima-media thickness in nondiabetic and type 2 diabetic subjects. Diabetes Care 2002; 25: 936-937.
32. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319-323.
33. Clausen P, Feldt-Rasmussen B, Jensen G, Jensen JS. Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study. Clin Sci 1999; 97: 37-43.
34. Prati P, Vanuzzo D, Casaroli M, Di Chiara A, De Biasi F, Feruglio GA et al. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke 1992; 23: 1705-1711.
35. Spijkerman AM, Dekker JM, Nijpels G, Jager A, Kostense PJ, Van Hinsbergh VW et al. Impact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoorn Study. Eur J Clin Invest 2002; 32: 924-930.
36. Clarkson P, Celermajer DS, Donald AE, Sampson M, Sorensen KE, Adams M et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels, J Am Coll Cardiol 1996; 28: 573-579.
37. Wagenknecht LE, D'Agostino R Jr, Savage PJ, O'Leary DH, Saad MF, Haffner SM. Duration of diabetes and carotid wall thickness. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1997; 28: 999-1005.
38. Wagenknecht LE, D'Agostino RB Jr, Haffner SM, Savage PJ, Rewers M. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Diabetes Care 1998; 21: 1812-1818.
39. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen male study. Circulation 1998; 97: 1029-1036.